サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1794615

末梢血管診断システムの世界市場

Peripheral Vascular Diagnostic Systems

出版日
ページ情報
英文 185 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.42円
末梢血管診断システムの世界市場
出版日: 2025年08月20日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 185 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

末梢血管診断システムの世界市場は2030年までに6億4,020万米ドルに達する見込み

2024年に4億4,730万米ドルと推定される末梢血管診断システムの世界市場は、2024年から2030年にかけてCAGR 6.2%で成長し、2030年には6億4,020万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである病院・診療所エンドユースは、CAGR 5.8%を記録し、分析期間終了時には3億7,890万米ドルに達すると予測されます。外来手術センター（Ambulatory Surgery Centers End-Use）セグメントの成長率は、分析期間中CAGR 7.0％と推定されます。

米国市場は1億2,190万米ドルと推定、中国はCAGR9.6％で成長予測

米国の末梢血管診断システム市場は、2024年に1億2,190万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに1億3,040万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは9.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.1%と6.0%と予測されています。欧州では、ドイツがCAGR 4.0%で成長すると予測されています。

世界の末梢血管診断システム市場- 主要動向と促進要因のまとめ

なぜ末梢血管診断システムが血管疾患管理の中心になりつつあるのか？

末梢血管診断システムは、心臓や脳以外の動脈や静脈の障害の検出や評価に使用されます。これらのシステムは末梢動脈疾患（PAD）、慢性静脈不全、深部静脈血栓症、動脈瘤の診断に役立ちます。糖尿病、喫煙、座りっぱなしのライフスタイルなどにより血管疾患の世界の負担が増加する中、四肢の虚血や脳卒中などの合併症を予防するためには、正確かつ早期の診断が不可欠となっています。

これらのシステムには通常、ドップラー超音波、足関節上腕血圧比（ABI）測定ツール、プレチスモグラフィー、および高度な画像診断モダリティが含まれます。外来診療所、血管研究所、プライマリケア施設に統合されることで、アクセス性が向上し、より日常的なスクリーニングが可能になりつつあります。PADは全身性アテローム性動脈硬化症の早期マーカーであるとの認識が高まり、予防心臓病学における血管診断の役割も増加しています。

技術の進歩はどのように精度と臨床的有用性を高めているのか？

非侵襲的診断システムは現在、早期疾患に対する感度を向上させ、より迅速で正確な結果を提供しています。高解像度プローブを備えたポータブルドップラー超音波システム、自動ABI測定装置、リアルタイム血流モニタリングツールは、患者の不快感を最小限に抑えながら迅速な評価を可能にしています。画像診断プラットフォームへの人工知能の統合は、臨床医がより効率的に結果を解釈し、診断のばらつきを減らすのに役立っています。

ABI、脈拍数記録、デュープレックス超音波を組み合わせたマルチモーダル診断装置が開発され、1回の検査で包括的な評価ができるようになっています。高度医療センターでは、デジタル血管画像システムが機能的・解剖学的情報を提供し、治療前の計画立案に役立っています。遠隔医療に対応した機器やクラウドベースの診断プラットフォームが登場し、特にサービスが行き届いていない地域での遠隔患者評価をサポートしています。

どこで導入が拡大し、どの施設が需要を牽引しているか？

診断システムは血管外科センター、外来クリニック、循環器科で広く使用されています。プライマリケア医もリスクのある患者を早期に特定するために基本的なABIスクリーニングツールを採用しています。北米と欧州は、確立された診療報酬体系と公衆衛生スクリーニング・プログラムに後押しされ、導入でリードしています。アジア太平洋では、生活習慣に関連した血管疾患の増加や専門診断センターの拡大により、利用が増加しています。

病院では、緊急時の評価や手術前のリスク評価を効率化するため、携帯型の血管診断ツールに投資しています。外来や地域医療の現場では、携帯型ABIシステムが迅速なPADスクリーニングに使用されています。糖尿病患者の血管合併症に対する一般開業医や内分泌専門医の意識が高まるにつれ、診断ソリューションに対する需要は都市部でも地方でも拡大しています。

末梢血管診断システム市場の成長はいくつかの要因によって牽引されています。

末梢血管診断システム市場の成長は、末梢血管障害の有病率の増加、非侵襲的診断ツールの技術進歩、リスク集団に対するスクリーニングイニシアチブの拡大などの要因によって牽引されます。糖尿病患者や高齢者人口の増加は、予防医療におけるABIやドップラーベースの評価の定期的な使用を促しています。

ポータブルで使いやすい診断機器の開発、AIを活用した画像解析の統合、早期介入の重視の高まりが市場開拓を後押ししています。プライマリ・ケア提供者の意識の向上は、外来診断インフラやデジタル・ヘルス・プラットフォームへの投資と相まって、血管診断へのアクセスを世界的に拡大する一助となっています。

セグメント

エンドユーザー（病院・クリニック、外来手術センター、医師オフィス）

調査対象企業の例

  • Abbott
  • ADInstruments
  • AngioDynamics
  • B. Braun Melsungen AG
  • Biopac Systems Inc.
  • Canon Medical Systems Corp
  • Carestream Health
  • Compumedics Limited
  • Cook Medical
  • ELCAT GmbH
  • Fukuda Denshi Co., Ltd.
  • GE HealthCare
  • Hitachi Medical Systems
  • KONINKLIJKE PHILIPS N.V.
  • Medtronic
  • MESI, Ltd.
  • Mindray Medical International
  • Natus Medical Incorporated
  • Siemens Healthineers
  • Vaso Corporation

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP37708

Global Peripheral Vascular Diagnostic Systems Market to Reach US$640.2 Million by 2030

The global market for Peripheral Vascular Diagnostic Systems estimated at US$447.3 Million in the year 2024, is expected to reach US$640.2 Million by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Hospitals & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$378.9 Million by the end of the analysis period. Growth in the Ambulatory Surgery Centers End-Use segment is estimated at 7.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$121.9 Million While China is Forecast to Grow at 9.6% CAGR

The Peripheral Vascular Diagnostic Systems market in the U.S. is estimated at US$121.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$130.4 Million by the year 2030 trailing a CAGR of 9.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 6.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Peripheral Vascular Diagnostic Systems Market - Key Trends & Drivers Summarized

Why Are Peripheral Vascular Diagnostic Systems Becoming Central to Vascular Disease Management?

Peripheral vascular diagnostic systems are used to detect and assess disorders in arteries and veins located outside the heart and brain. These systems help diagnose peripheral artery disease (PAD), chronic venous insufficiency, deep vein thrombosis, and aneurysms. As the global burden of vascular disease increases due to diabetes, smoking, and sedentary lifestyles, accurate and early diagnosis has become essential to prevent complications such as limb ischemia or stroke.

These systems typically include Doppler ultrasound, ankle-brachial index (ABI) measurement tools, plethysmography, and advanced imaging modalities. Integration into outpatient clinics, vascular labs, and primary care facilities is improving accessibility and enabling more routine screening. Growing recognition of PAD as an early marker of systemic atherosclerosis is increasing the role of vascular diagnostics in preventive cardiology as well.

How Are Technology Advancements Enhancing Accuracy and Clinical Usefulness?

Non-invasive diagnostic systems now offer faster, more accurate results with improved sensitivity for early-stage disease. Portable Doppler ultrasound systems with high-resolution probes, automated ABI measurement devices, and real-time blood flow monitoring tools are allowing quicker assessments with minimal patient discomfort. Integration of artificial intelligence into imaging platforms is helping clinicians interpret results more efficiently and reduce diagnostic variability.

Multimodal diagnostic units that combine ABI, pulse volume recording, and duplex ultrasound are being developed to offer comprehensive assessments in a single session. In advanced care centers, digital vascular imaging systems provide functional and anatomical information, assisting in pre-procedural planning. Telemedicine-compatible devices and cloud-based diagnostic platforms are emerging to support remote patient assessment, especially in underserved regions.

Where Is Adoption Expanding and Which Facilities Are Driving Demand?

Diagnostic systems are widely used in vascular surgery centers, outpatient clinics, and cardiology departments. Primary care physicians are also adopting basic ABI screening tools to identify at-risk patients early. North America and Europe lead in deployment, aided by established reimbursement structures and public health screening programs. Asia-Pacific is seeing increasing usage due to the rise in lifestyle-related vascular diseases and expansion of specialty diagnostic centers.

Hospitals are investing in portable vascular diagnostic tools to streamline emergency evaluations and pre-operative risk assessments. In ambulatory and community care settings, portable ABI systems are being used for rapid PAD screening. As awareness grows among general practitioners and endocrinologists about vascular complications in diabetic patients, demand for diagnostic solutions is expanding in both urban and rural settings.

Growth in the Peripheral Vascular Diagnostic Systems market is driven by several factors…

Growth in the peripheral vascular diagnostic systems market is driven by factors such as increasing prevalence of peripheral vascular disorders, technological advancements in non-invasive diagnostic tools, and expanding screening initiatives for at-risk populations. Rising diabetic and elderly populations are prompting regular use of ABI and Doppler-based assessments in preventive care.

Development of portable, user-friendly diagnostic devices, integration of AI-driven imaging analysis, and growing emphasis on early intervention are supporting market adoption. Improved awareness among primary care providers, combined with investment in outpatient diagnostic infrastructure and digital health platforms, is helping expand access to vascular diagnostics globally.

SCOPE OF STUDY:

The report analyzes the Peripheral Vascular Diagnostic Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use, Physician Office End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Abbott
  • ADInstruments
  • AngioDynamics
  • B. Braun Melsungen AG
  • Biopac Systems Inc.
  • Canon Medical Systems Corp
  • Carestream Health
  • Compumedics Limited
  • Cook Medical
  • ELCAT GmbH
  • Fukuda Denshi Co., Ltd.
  • GE HealthCare
  • Hitachi Medical Systems
  • KONINKLIJKE PHILIPS N.V.
  • Medtronic
  • MESI, Ltd.
  • Mindray Medical International
  • Natus Medical Incorporated
  • Siemens Healthineers
  • Vaso Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Peripheral Vascular Diagnostic Systems - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Peripheral Artery Disease (PAD) Spurs Demand for Early and Accurate Vascular Diagnostic Tools
    • Shift Toward Non-Invasive and Point-of-Care Testing Strengthens Adoption of Doppler, ABI, and Segmental Pressure Systems
    • Technological Advancements in Duplex Ultrasound and PPG Devices Enhance Precision and Real-Time Blood Flow Assessment
    • Growth in Geriatric and Diabetic Populations Throws the Spotlight on Routine PAD Screening and Surveillance
    • OEM Focus on Portable and Wireless Diagnostic Platforms Supports Use in Clinics, Mobile Units, and Remote Health Centers
    • Increased Emphasis on Early Detection of Asymptomatic Vascular Disease Drives Utilization in Primary Care Settings
    • Integration With EMR Systems and PACS Enhances Workflow Efficiency and Diagnostic Record Management
    • Expansion of Hybrid Imaging Solutions Combines Anatomical and Functional Analysis for Advanced Vascular Assessment
    • Growing Demand for Real-Time Monitoring in Interventional Procedures Supports Intraoperative Use of Vascular Imaging Tools
    • OEM Development of Multi-Modality Systems With AI Interpretation Capabilities Enhances Decision-Making in Complex Cases
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Peripheral Vascular Diagnostic Systems Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Peripheral Vascular Diagnostic Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Peripheral Vascular Diagnostic Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Physician Office End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Physician Office End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Physician Office End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Peripheral Vascular Diagnostic Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • JAPAN
    • Peripheral Vascular Diagnostic Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • CHINA
    • Peripheral Vascular Diagnostic Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: China 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • EUROPE
    • Peripheral Vascular Diagnostic Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Peripheral Vascular Diagnostic Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Peripheral Vascular Diagnostic Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • FRANCE
    • Peripheral Vascular Diagnostic Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: France 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • GERMANY
    • Peripheral Vascular Diagnostic Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Peripheral Vascular Diagnostic Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: Spain 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Russia 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Peripheral Vascular Diagnostic Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Peripheral Vascular Diagnostic Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Peripheral Vascular Diagnostic Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Peripheral Vascular Diagnostic Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: Australia 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • INDIA
    • Peripheral Vascular Diagnostic Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: India 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: South Korea 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Peripheral Vascular Diagnostic Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Peripheral Vascular Diagnostic Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Peripheral Vascular Diagnostic Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: Argentina 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Brazil 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Mexico 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Rest of Latin America 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Peripheral Vascular Diagnostic Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Peripheral Vascular Diagnostic Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Peripheral Vascular Diagnostic Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Iran 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Israel 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Saudi Arabia 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: UAE 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Rest of Middle East 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030
  • AFRICA
    • Peripheral Vascular Diagnostic Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Peripheral Vascular Diagnostic Systems by End-Use - Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Africa 16-Year Perspective for Peripheral Vascular Diagnostic Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Ambulatory Surgery Centers End-Use and Physician Office End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION